Drug Class Monitoring

Drug Class Monitoring is a systematic pharmacovigilance framework that enables the ongoing evaluation of the safety, efficacy, and utilization patterns of a group of pharmacologically related therapeutic agents to inform clinical decision-making and regulatory policy.

9

Publications

298

Citations

29

Authors

15

Institutions

Publications per year

2017–2026

2

Variants

Therapeutic Class Monitoring

Authors

29

  1. JF
    Joseph F. Dasta

    The Ohio State University, United States

    1 publications · 22 citations

    1

    h-index

  2. OS
    Olivier Steichen

    Sorbonne Université, France

    1 publications · 42 citations

    1

    h-index

  3. RD
    Rishi Desai

    Brigham and Women's Hospital, United States

    1 publications · 17 citations

    1

    h-index

  4. MH
    Mark Helfand

    Oregon Health & Science University, United States

    1 publications · 10 citations

    1

    h-index

  5. CS
    Cormac Sheridan

    Simon Fraser University, Canada

    1 publications · 20 citations

    1

    h-index

1–5 of 29

Venues

  1. Nature Biotechnology

    1 publications · 20 citations

    1

    h-index

  2. Journal of Hypertension

    1 publications · 42 citations

    1

    h-index

  3. Escola Anna Nery

    1 publications · 16 citations

    1

    h-index

  4. JAMA

    1 publications · 17 citations

    1

    h-index

  5. Drug Intelligence & Clinical Pharmacy

    1 publications · 22 citations

    1

    h-index

1–5